Browsing by Subject/keywords Molecularly Targeted Therapy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
PreviewIssue DateTitle / NameAuthor(s)Type
2018Cardiotoxicity in advanced HER2 positive breast cancer in real world Australian patients receiving HER2-targeted therapy in the first-line settingConduit, C.; King, Rossa; De Boer, Richard; Gibbs, Peter; Lok, Sheau Wen, et alConference Paper 
2019Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two yearsMileshkin, Linda R.; Sivakumaran, Tharani; Etemadmoghadam, Dariush; Tothill, Richard; Fellowes, Andrew, et alConference Paper 
medRxiv - 2022 - The DNA sequencing and gene-expression profiling assists in making a tissue of origine diagnosis in cancer of unknown primary.pdf.jpgJun-2022DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primaryPosner, A.; Prall, Owen W. J.; Sivakumaran, Tharani; Etemadamoghadam, D.; Thio, N., et alJournal Article 
2021Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based studyTung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et alConference Paper